New funding announced to support access to COVID-19 vaccines
North Carolina has announced the next round of funding aimed at ensuring an equitable response to the COVID-19 pandemic.
COVID-19
Coronavirus FAQ: Help me with omicron vocab. What's immune evasion? Epistasis?
The emergence of this new variant of concern has brought a new vocabulary into daily news reports. We asked experts to help define the terms you're being bombarded with.
How Pfizer developed a COVID pill in record time
Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.
5 states have now reported confirmed cases of the omicron variant
Officials in Colorado, Hawaii, Minnesota and New York reported their first cases of the variant on Thursday, one day after the first U.S. case was identified in California.
Sending the right message about the omicron variant is tricky
Scientists may not know for a couple weeks yet how risky the new coronavirus variant will be to public health. But getting out front now about what is known helps dispel misinformation, they say.
The omicron variant has been found in 24 countries
More should be known about the transmissibility and severity of the new variant in "days, not necessarily weeks," a senior World Health Organization scientist says.
A different kind of COVID vaccine is about ready to roll
Protein subunit vaccines work by injecting people with a tiny portion of a virus. In the case of the COVID-19 vaccine, that tiny portion is the spike protein that the coronavirus uses to enter cells.
WHO member states will work on a global agreement to deal with future pandemics
The coronavirus outbreak exposed flaws in the global health system but also showed a willingness among countries to work together, Tedros Adhanom Ghebreyesus, the WHO's director-general, says.
Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.
The World Health Organization warns of very high risk posed by the omicron variant
The newly identified strain of the coronavirus, which could be more transmissible than the previously dominant delta variant, has global health officials worried about a possible new surge in cases.